Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Allo-HCT in CLL after multiple pathway inhibitors.

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Michel van Gelder/Olivier Tournilhac

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres.

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

Retrospective Studies

Myelodysplastic (MDS) or MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

MDS ATG versus Post-Cy in unrelated donors

Retrospective Studies

Myelodysplastic (MDS) or MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

Yves Chalandon, Marie Robin

CLL - Projects about PI, ibrutinib and venetoclax

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Olivier Tournilhac, Michel van Gelder